KELLOGG CO (K)       67.6  +0.08 (+0.12%)

67.6  +0.08 (+0.12%)

US4878361082 - Common Stock - After market: 67.9 +0.3 (+0.44%)


Fundamental Rating

5

Taking everything into account, K scores 5 out of 10 in our fundamental rating. K was compared to 103 industry peers in the Food Products industry. K has a great profitability rating, but there are some minor concerns on its financial health. While showing a medium growth rate, K is valued expensive at the moment.




Profitability

Profitability Rating

7

K's Return On Assets of 7.84% is amongst the best of the industry. K does better than the industry average Return On Assets of 6.01%.
K's Return On Equity of 34.81% is amongst the best returns of the industry. K outperforms 91% of its industry peers. The industry average return on equity is 14.51%.

K's Profit Margin of 10.01% is amongst the best of the industry. K does better than the industry average Profit Margin of 5.66%.
K has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for K.
VS Industry

ROA (7.84%) VS Industry: 67% outperformed.

0.13
26.84

ROE (34.81%) VS Industry: 91% outperformed.

0.23
82.65

Profit Margin (10.01%) VS Industry: 69% outperformed.

0.08
41.73

Valuation

Valuation Rating

3

K's Price/Earning Ratio is a bit cheaper than the industry average which is at 21.35.
With a Price/Earnings Ratio of 16.41, K is valued correctly.
The Forward Price/Earnings Ratio of 15.95 indicates a correct valuation of K.
With a price book ratio of 5.39, K is valued correctly.

Compared to an average industry Enterprise Value to EBITDA ratio of 14.27, K is valued in line with its industry peers.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
When comparing the price book ratio of K to the average industry price book ratio of 1.89, K is valued more expensive than its industry peers. 92% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (16.41) VS Industry: 64% outperformed.

549.00
5.67

Price/Book (5.39) VS Industry: 8% outperformed.

250.05
0.03

Enterprise Value/ EBITDA (13.73) VS Industry: 52% outperformed.

663.57
0.23

Growth

Growth Rating

5

The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
K shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.90%.
K shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 2.09% yearly.

The Earnings Per Share is expected to grow by 6.23% on average over the next 5 years.
Looking at the last year, K shows a small growth in Revenue. The Revenue has grown by 4.76% in the last year.
K shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 1.81% yearly.
Based on estimates for the next 5 years, K will show a small growth in Revenue. The Revenue will grow by 3.52% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS2.09% -1.32% -1.9% 1.28% 0.81% 2.08% 6.23%
Revenue1.81% 1.54% 4.76% 7.04% 4.58% 3.55% 3.52%

Health

Health Rating

4

When comparing the Altman-Z score to an average industry score of 2.20, K is in better financial health than the average industry peer.
The Piotroski-F score of K is 7.00. This is a strong score and indicates good health and profitability for K.
An Altman-Z score of 2.61 indicates that K is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Current Ratio of 0.74 indicates that K may have some problems paying its short term obligations.

Compared to an average industry Current Ratio of 1.80, K is worse placed to pay its short term obligations than its industry peers. 88% of its industry peers have a better Current Ratio.
K has a Quick Ratio of 0.74. This is a bad value and indicates that K is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Quick Ratio of K to the average industry Current Ratio of 0.90, K is less able to pay its short term obligations than its industry peers. 82% of its industry peers have a better Quick Ratio.
K has one of the worst Debt to Equity ratios in its industry. 90% of its industry peers require less debt for financing their operations.
VS Industry

Debt/Equity (1.33) VS Industry: 10% outperformed.

53.34
0.00

Quick Ratio (0.46) VS Industry: 18% outperformed.

0.01
48.00

Current Ratio (0.74) VS Industry: 12% outperformed.

0.01
49.63

Altman-Z (2.61) VS Industry: 61% outperformed.

-34.87
69.75

Dividend

Dividend Rating

6

Compared to an average industry Dividend Yield of 2.97, K pays a bit more dividend than its industry peers.
K's Dividend Yield is a higher than the S&P500 average which is at 2.41.
K has paid a dividend for at least 10 years, which is a reliable track record.
K has a Yearly Dividend Yield of 3.50%.

The dividend of K has a limited annual growth rate of 1.64%.
53.25% of the earnings are spent on dividend by K. This is a bit on the high side, but may be sustainable.
The dividend of K is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (3.5%) VS Industry: 68% outperformed.

0.73
17.92

KELLOGG CO67.6

NYSE:K (1/27/2023, 7:17:57 PM)+0.08 (+0.12%)

After market: 67.9 +0.3 (+0.44%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Food Products
Earnings (Last) 11-03 2022-11-03/bmo Earnings (Next) 02-09 2023-02-09
Inst Owners 84.1% Inst Owner Change -0.02%
Ins Owners 16.45% Ins Owner Change -2.52%
Market Cap 23.07B Analysts 53.57
Price Target 74.72 (10.53%)

Dividend
Dividend Yield 3.5% Dividend Growth 1.64%
DP 53.25% Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 5.62%
Min EPS beat(2) 1.03% Max EPS beat(2) 10.21%
EPS beat(4) 4 Avg EPS beat(4) 7.6%
Min EPS beat(4) 1.03% Max EPS beat(4) 15.99%
Revenue beat(2) 2 Avg Revenue beat(2) 3.22%
Min Revenue beat(2) 2.31% Max Revenue beat(2) 4.12%
Revenue beat(4) 3 Avg Revenue beat(4) 1.42%
Min Revenue beat(4) -1.16% Max Revenue beat(4) 4.12%
PT rev (1m) -0.13% EPS NQ rev (1m) 0%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 0%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 16.41
Fwd PE 15.95
P/S 1.55
P/FCF 18.59
P/OCF 13.29
P/B 5.39
P/tB N/A
EV/EBITDA 13.73
EPS(TTM) 4.12 EY 6.09%
EPS(NY) 4.24 Fwd EY 6.27%
FCF(TTM) 3.64 FCFY 5.38%
OCF(TTM) 5.09 OCFY 7.52%
SpS 43.66 BVpS 12.55
TBVpS -10.87 PEG (NY) 12.86
PEG (5Y) 7.84

Profitability
Industry RankSector Rank
ROA 7.84%
ROE 34.81%
ROIC 9.93%
ROICexc 10.21%
ROICexgc 27.26%
OM 11.11%
PM 10.01%
GM 30.05%
ROICexgc(3y) 31.29% ROICexcg growth 3Y -4.5%
ROICexcg growth 5Y -2.67% ROICexc(3y) 10.59%
ROICexc growth 3Y 3.28% ROICexc growth 5Y 0.62%
OM growth 3Y 0.69% OM growth 5Y 2.12%
PM growth 3Y 2.09% PM growth 5Y 14.25%
GM growth 3Y -1.74% GM growth 5Y -2.12%
F-Score 7 Asset Turnover 0.78

Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF 5.39
Debt/EBITDA 3.14
Cap/Depr 104.87%
Profit Quality 83.23%
Current Ratio 0.74
Quick Ratio 0.46
Altman-Z 2.61
F-Score 7 WACC 6.75%
ROIC/WACC 4.04 Cap/Depr(3y) 114.97%
Cap/Depr(5y) 112.22% Profit Quality(3y) 85.66%
Profit Quality(5y) N/A

Growth
EPS 1Y -1.9% EPS 3Y -1.32%
EPS 5Y 2.09% EPS growth Q2Q -7.34%
EPS Next Y 1.28% EPS Next 2Y 0.81%
EPS Next 3Y 2.08% EPS Next 5Y 6.23%
Revenue growth 1Y 4.76% Revenue growth 3Y 1.54%
Revenue growth 5Y 1.81% Revenue growth Q2Q 8.95%
Revenue Next Year 7.04% Revenue Next 2Y 4.58%
Revenue Next 3Y 3.55% Revenue Next 5Y 3.52%
EBIT growth 1Y -4.88% EBIT growth 3Y 2.24%
EBIT growth 5Y 3.96% EBIT Next Year 30.77%
EBIT Next 3Y 11.73% EBIT Next 5Y 10.65%
FCF growth 1Y -9.28% FCF growth 3Y 6.22%
FCF growth 5Y 8.49% OCF growth 1Y -5.86%
OCF growth 3Y 3.46% OCF growth 5Y 6%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA